SCHEMBL5794547

SCHEMBL5794547

NN(C(=O)O)c1cccc(NC(=O)c2sccc2NCc2ccnc3ccccc23)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 10/20 0.60
KIT P10721 2/20 0.60
RAF1 P04049 1/20 0.60
LCK P06239 1/20 0.60
RET P07949 1/20 0.60
CYP3A4 P08684 1/20 0.60
MAP3K20 Q9NYL2 1/20 0.60
RIPK3 Q9Y572 1/20 0.60
FLT1 P17948 6/20 0.51
MAPK8 P45983 2/20 0.41
MAPK9 P45984 2/20 0.41
MAPK10 P53779 2/20 0.41
BRAF P15056 1/20 0.39
DNMT1 P26358 2/20 0.38
DNMT3A Q9Y6K1 1/20 0.38
FAAH O00519 1/20 0.38
KCNK3 O14649 1/20 0.36
KCNK9 Q9NPC2 1/20 0.36
CLK1 P49759 1/20 0.36
NTSR1 P30989 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5792920 0.90 KDR (0.68) KDRKITRAF1LCKRET
SCHEMBL5794532 0.86 KDR (0.65) KDRKITRAF1LCKRET
SCHEMBL3745389 0.86 KDR (0.65) KDRKITRAF1LCKRET
SCHEMBL5790482 0.85 KDR (0.60) KDRKITRAF1LCKRET
SCHEMBL14044954 0.85 KDR (0.63) KDRKITRAF1LCKRET
SCHEMBL13043427 0.84 KDR (0.65) KDRKITRAF1LCKRET
SCHEMBL3732625 0.82 KDR (0.60) KDRKITRAF1LCKRET
SCHEMBL14044850 0.81 KDR (0.61) KDRKITRAF1LCKRET
SCHEMBL14044881 0.81 KDR (0.61) KDRKITRAF1LCKRET
SCHEMBL5792923 0.81 KDR (0.73) KDRKITRAF1LCKRET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006034110-A1 (ARYLAMIDOARYL) CYANOGUANIDINE COMPOUNDS AS INHIBITORS OF C-KIT PROTO-ONCOGENE OSI PHARMACEUTICALS, INC. (US) 2006-03-30 WO disclosed